mounjaro vs generic tirzepatide 🚨 Versions of & Zepbound Move Closer as FDA Reviews First Applications The US Food and Drug Administration (FDA) is reviewing the first applications for generic versions of Eli Lilly's Tirzepatide vs Mounjaro: Are They

Apovian, MD, FTOS, co-director, Center for Weight Management and Wellness and professor of medicine at Harvard Medical School in Boston, Mass., commented, Once we have shown that anti-obesity agents notably GLP-1 and combinations thereof lower cardiovascular risk, we can then demand universal insurance coverage of these agents

More serious risks include pancreatitis, gallbladder disease, acute kidney injury (particularly with dehydration), hypoglycemia (when combined with insulin or sulfonylureas), and thyroid C-cell tumors in animal studies

Weight loss also leads to a decrease in GLP-1 and changes other appetite-related hormones, which can prompt you to eat to get back up to your baseline weight

Its not about being perfect